We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
+26.96%
1 Year Est. Return
-57.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$233M
AUM Growth
Cap. Flow
+$239M
Cap. Flow %
102.7%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$117M
2
RAPT
RAPT Therapeutics
RAPT
+$52.9M
3
UPST icon
Upstart Holdings
UPST
+$34.8M
4
ATRA icon
Atara Biotherapeutics
ATRA
+$34.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 54.29%
2 Healthcare 32.35%
3 Financials 13.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWLO icon
1
Twilio
TWLO
$27.8B
$126M 54.29%
+373,333
New +$117M
RAPT
2
DELISTED
RAPT Therapeutics
RAPT
$38.5M 16.52%
+243,383
New +$52.9M
ATRA icon
3
Atara Biotherapeutics
ATRA
$73.3M
$36.8M 15.83%
+75,066
New +$34.7M
UPST icon
4
Upstart Holdings
UPST
$2.74B
$31.1M 13.36%
+847,788
New +$34.8M

Similar funds

KPCB XV Associates's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for KPCB XV Associates, which disclosed 4 positions worth $233M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Twilio: 373,333 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, followed by Healthcare and Financials.

  • KPCB XV Associates's largest Q4 2020 buy was Twilio: 373,333 shares worth $126M.
  • KPCB XV Associates's ten largest holdings make up 100% of its $233M portfolio in Q4 2020.
  • KPCB XV Associates disclosed 4 positions in Q4 2020, its first 13F filing on record.

Based on KPCB XV Associates's 13F filing for Q4 2020, filed 16 Feb 2021.